ArticleLancet (London, England)2021
Tocilizumab in COVID-19 therapy: who benefits, and how?
Avidan U Neumann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleLancet (London, England)2021
Avidan U Neumann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.